Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
307-02-001 ISMRM Abstract

Diffusion-Weighted MRI Radiomics Model in Predicting IDH Status of Non-Enhancing (Low-Grade-Appearing) Adult Diffuse Gliomas

Primary: Neuro - Tumors
Secondary: Analysis Methods - Radiomics
307-02-001 · Advances in MRI Radiomics for Disease Characterization and Outcome Prediction · Monday, 11 May, 8:20 AM–10:10 AM · Meeting Room 1.40
Keywords: Radiomics Glioma Isocitrate Dehydrogenase
Accepted
Yuhan Liang1, Yanhong Liu2, Zelong Chen2, Menglin Ge 2, Yulin Wang2
1Chinese PLA Medical School, Chinese PLA General Hospital, Beijing, China
2Chinese PLA General Hospital, Beijing, China
Presenting Author: Menglin Ge

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. [1]Eichberg D G, Di L, Morell A A, et al. Incidence of high grade gliomas presenting as radiographically non-enhancing lesions: experience in 111 surgically treated non-enhancing gliomas with tissue diagnosis[J]. Journal of Neuro-Oncology, J Neurooncol, 2020, 147(3): 671–679.
2. [2]Kudulaiti N, Zhang H, Qiu T, et al. The Relationship Between IDH1 Mutation Status and Metabolic Imaging in Nonenhancing Supratentorial Diffuse Gliomas: A 11C-MET PET Study[J]. Molecular Imaging, Mol Imaging, 2019, 18.Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW.
3. [3]The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106. PMID: 34185076; PMCID: PMC8328013. [doi] [pmid]
4. [4]Smith HL, Wadhwani N, Horbinski C. Major Features of the 2021 WHO Classification of CNS Tumors. Neurotherapeutics. 2022 Oct;19(6):1691-1704. doi: 10.1007/s13311-022-01249-0. Epub 2022 May 16. PMID: 35578106; PMCID: PMC9723092. [doi] [pmid]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/307-02-001